Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,056 | Dovepress* | 4,394+ | 985 | 5,379 | |
| PubMed Central* | 662 | 217 | 879 | ||
| Totals | 5,056 | 1,202 | 6,258 | ||
| *Since 8 April 2019 | |||||
View citations on PubMed Central and Google Scholar